# ABCA1

## Overview
The ABCA1 gene encodes the ATP-binding cassette subfamily A member 1 (ABCA1) protein, a crucial component of the ATP-binding cassette (ABC) transporter family. This transmembrane protein plays a pivotal role in lipid metabolism by mediating the efflux of cholesterol and phospholipids to apolipoproteins, which is essential for the formation of high-density lipoprotein (HDL) particles. These particles are integral to reverse cholesterol transport, a process that helps maintain cellular lipid homeostasis and prevent atherosclerosis (Liu2012Regulation; Zarubica2006ABCA1). The ABCA1 protein is primarily located in the plasma membrane of cells such as macrophages and hepatocytes, where it facilitates cholesterol balance (Denis2003Expression). Mutations in the ABCA1 gene are associated with disorders like Tangier disease and familial hypoalphalipoproteinemia, which are characterized by altered HDL levels and increased cardiovascular risk (Clee2000Age; Jacobo-Albavera2021The).

## Structure
The ABCA1 protein is a member of the ATP-binding cassette (ABC) transporter family, characterized by its complex structure. It is encoded by a gene on chromosome 9q31, consisting of 50 exons spanning approximately 150 kb (Schmitz2001Structure). The protein is a 2261 amino acid polypeptide with a molecular mass of 254 kDa (Schmitz2001Structure). Its primary structure includes two transmembrane domains (TMDs), each containing six membrane-spanning α-helices, and two nucleotide-binding domains (NBDs) (Kaminski2006ABC). 

The secondary structure features conserved motifs such as Walker A and B motifs within the NBDs, essential for ATP binding and hydrolysis (Langmann1999Molecular). The tertiary structure involves a large extracellular loop between the first and second transmembrane helices, which may contain glycosylation sites (Kaminski2006ABC). 

ABCA1's quaternary structure may involve dimerization, as it is suggested that an NBD-TMD dimer is the minimum unit required for transport function (MarínMartín2014A). Post-translational modifications include glycosylation of large extracellular loops and potential phosphorylation sites, which may influence the protein's function and regulation (Schmitz2001Structure; MarínMartín2014A).

## Function
The ABCA1 gene encodes a protein that plays a critical role in lipid metabolism by facilitating the efflux of cholesterol and phospholipids from cells to lipid-poor apolipoproteins, such as apolipoprotein A-I (apoA-I). This process is essential for the formation of high-density lipoprotein (HDL) particles, which are crucial for reverse cholesterol transport, a mechanism that helps maintain cellular lipid homeostasis and prevent atherosclerosis (Liu2012Regulation; Zarubica2006ABCA1).

ABCA1 is primarily active in the plasma membrane of cells, including macrophages and hepatocytes, where it facilitates the removal of excess cholesterol, thus maintaining cholesterol balance within the cell (Denis2003Expression; Zarubica2006ABCA1). The protein also localizes to the endo-lysosomal compartment, suggesting a role in lipid handling through endocytic recycling (Zarubica2006ABCA1).

The interaction of apolipoproteins with ABCA1 activates several signaling pathways, such as JAK2/STAT3, which are involved in lipid efflux and have anti-inflammatory effects (Liu2012Regulation). This interaction is crucial for the anti-inflammatory effects of apoA-I, as it suppresses inflammatory cytokine production in macrophages (Liu2012Regulation). The protein's function involves ATP hydrolysis, which drives conformational changes necessary for lipid transport (Liu2012Regulation).

## Clinical Significance
Mutations in the ABCA1 gene are linked to several diseases, primarily due to their impact on cholesterol metabolism. Tangier disease is a rare autosomal recessive disorder caused by homozygous or compound heterozygous mutations in ABCA1, leading to a severe deficiency of high-density lipoprotein cholesterol (HDL-C) and accumulation of cholesteryl esters in cells. Clinical manifestations include very low HDL-C levels, hyperplastic yellow-orange tonsils, hepatosplenomegaly, peripheral neuropathy, and an increased risk of premature coronary heart disease (CHD) (Jacobo-Albavera2021The). Familial hypoalphalipoproteinemia, a milder condition, results from heterozygous mutations in ABCA1 and is characterized by reduced HDL-C levels and increased risk of coronary artery disease (CAD) (Clee2000Age).

ABCA1 mutations also contribute to other conditions. For instance, a missense mutation, R1925Q, is associated with Scott syndrome, a rare bleeding disorder (Brunham2006Variations). Variations in ABCA1 are linked to type 2 diabetes (T2D) in certain populations, with specific polymorphisms like R230C associated with early-onset T2D (Jacobo-Albavera2021The). Additionally, ABCA1 polymorphisms can influence cardiovascular disease risk, with some variants offering protection against coronary heart disease, while others increase susceptibility (Wang2022Role).

## Interactions
ABCA1 interacts with several proteins that influence its function in lipid transport and cholesterol efflux. It directly binds to apolipoprotein A-I (apoA-I), a major component of high-density lipoprotein (HDL), facilitating cholesterol and phospholipid efflux. This interaction is crucial for the formation of HDL and is mediated by electrostatic forces involving lysine residues in ABCA1 (Nagao2012Lysine; Fitzgerald2002Naturally). Mutations in the extracellular loops of ABCA1 can disrupt its interaction with apoA-I, affecting cholesterol efflux (Fitzgerald2002Naturally).

ABCA1 also interacts with caveolin-1, a protein involved in cholesterol transport, on the cell surface. This interaction is important for cholesterol efflux and occurs in conjunction with HDL, although caveolin-1 does not directly bind HDL (Chao2005Cellular).

SPTLC1, another interacting protein, binds to ABCA1 and negatively regulates its trafficking and cholesterol efflux activity. This interaction can be inhibited by pharmacological agents, leading to increased ABCA1 activity (Tamehiro2008SPTLC1).

ABCA1's interactions with these proteins highlight its role in maintaining cholesterol homeostasis and its potential impact on conditions like atherosclerosis.


## References


[1. (Liu2012Regulation) Yuhua Liu and Chongren Tang. Regulation of abca1 functions by signaling pathways. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1821(3):522–529, March 2012. URL: http://dx.doi.org/10.1016/j.bbalip.2011.08.015, doi:10.1016/j.bbalip.2011.08.015. This article has 68 citations.](https://doi.org/10.1016/j.bbalip.2011.08.015)

[2. (MarínMartín2014A) Francisco R. Marín-Martín, Cristina Soler-Rivas, Roberto Martín-Hernández, and Arantxa Rodriguez-Casado. A comprehensive in silico analysis of the functional and structural impact of nonsynonymous snps in the abca1 transporter gene. Cholesterol, 2014:1–19, August 2014. URL: http://dx.doi.org/10.1155/2014/639751, doi:10.1155/2014/639751. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1155/2014/639751)

[3. (Chao2005Cellular) Wei-Ting Chao, Shu-Huai Tsai, Yu-Chun Lin, Wei-Wen Lin, and Vivian C. Yang. Cellular localization and interaction of abca1 and caveolin-1 in aortic endothelial cells after hdl incubation. Biochemical and Biophysical Research Communications, 332(3):743–749, July 2005. URL: http://dx.doi.org/10.1016/j.bbrc.2005.05.019, doi:10.1016/j.bbrc.2005.05.019. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2005.05.019)

[4. (Clee2000Age) Susanne M. Clee, John J.P. Kastelein, Marjel van Dam, Michel Marcil, Kirsten Roomp, Karin Y. Zwarts, Jennifer A. Collins, Roosje Roelants, Naoki Tamasawa, Tomás Stulc, Toshihiro Suda, Richard Ceska, Betsie Boucher, Colette Rondeau, Christele DeSouich, Angela Brooks-Wilson, Henri O.F. Molhuizen, Jiri Frohlich, Jacques Genest, and Michael R. Hayden. Age and residual cholesterol efflux affect hdl cholesterol levels and coronary artery disease in abca1 heterozygotes. Journal of Clinical Investigation, 106(10):1263–1270, November 2000. URL: http://dx.doi.org/10.1172/jci10727, doi:10.1172/jci10727. This article has 266 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci10727)

[5. (Tamehiro2008SPTLC1) Norimasa Tamehiro, Suiping Zhou, Keiichiro Okuhira, Yair Benita, Cari E. Brown, Debbie Z. Zhuang, Eicke Latz, Thorsten Hornemann, Arnold von Eckardstein, Ramnik J. Xavier, Mason W. Freeman, and Michael L. Fitzgerald. Sptlc1 binds abca1 to negatively regulate trafficking and cholesterol efflux activity of the transporter. Biochemistry, 47(23):6138–6147, May 2008. URL: http://dx.doi.org/10.1021/bi800182t, doi:10.1021/bi800182t. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi800182t)

[6. (Jacobo-Albavera2021The) Leonor Jacobo-Albavera, Mayra Domínguez-Pérez, Diana Jhoseline Medina-Leyte, Antonia González-Garrido, and Teresa Villarreal-Molina. The role of the atp-binding cassette a1 (abca1) in human disease. International Journal of Molecular Sciences, 22(4):1593, February 2021. URL: http://dx.doi.org/10.3390/ijms22041593, doi:10.3390/ijms22041593. This article has 103 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22041593)

[7. (Nagao2012Lysine) Kohjiro Nagao, Yasuhisa Kimura, and Kazumitsu Ueda. Lysine residues of abca1 are required for the interaction with apoa-i. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1821(3):530–535, March 2012. URL: http://dx.doi.org/10.1016/j.bbalip.2011.06.024, doi:10.1016/j.bbalip.2011.06.024. This article has 18 citations.](https://doi.org/10.1016/j.bbalip.2011.06.024)

[8. (Kaminski2006ABC) Wolfgang E. Kaminski, Armin Piehler, and Jürgen J. Wenzel. Abc a-subfamily transporters: structure, function and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1762(5):510–524, May 2006. URL: http://dx.doi.org/10.1016/j.bbadis.2006.01.011, doi:10.1016/j.bbadis.2006.01.011. This article has 147 citations.](https://doi.org/10.1016/j.bbadis.2006.01.011)

[9. (Fitzgerald2002Naturally) Michael L. Fitzgerald, Andrea L. Morris, Jeongmi S. Rhee, Lorna P. Andersson, Armando J. Mendez, and Mason W. Freeman. Naturally occurring mutations in the largest extracellular loops of abca1 can disrupt its direct interaction with apolipoprotein a-i. Journal of Biological Chemistry, 277(36):33178–33187, September 2002. URL: http://dx.doi.org/10.1074/jbc.M204996200, doi:10.1074/jbc.m204996200. This article has 253 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M204996200)

[10. (Schmitz2001Structure) Gerd Schmitz and Thomas Langmann. Structure, function and regulation of the abc1 gene product. Current Opinion in Lipidology, 12(2):129–140, April 2001. URL: http://dx.doi.org/10.1097/00041433-200104000-00006, doi:10.1097/00041433-200104000-00006. This article has 170 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/00041433-200104000-00006)

[11. (Denis2003Expression) Maxime Denis, Rachel Bissonnette, Bassam Haidar, Larbi Krimbou, Michel Bouvier, and Jacques Genest. Expression, regulation, and activity of abca1 in human cell lines. Molecular Genetics and Metabolism, 78(4):265–274, April 2003. URL: http://dx.doi.org/10.1016/s1096-7192(03)00020-9, doi:10.1016/s1096-7192(03)00020-9. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s1096-7192(03)00020-9)

[12. (Langmann1999Molecular) Thomas Langmann, Jochen Klucken, Markus Reil, Gerhard Liebisch, Marie-Françoise Luciani, Giovanna Chimini, Wolfgang E. Kaminski, and Gerd Schmitz. Molecular cloning of the human atp-binding cassette transporter 1 (habc1): evidence for sterol-dependent regulation in macrophages. Biochemical and Biophysical Research Communications, 257(1):29–33, April 1999. URL: http://dx.doi.org/10.1006/bbrc.1999.0406, doi:10.1006/bbrc.1999.0406. This article has 407 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/bbrc.1999.0406)

[13. (Brunham2006Variations) Liam R. Brunham, Roshni R. Singaraja, and Michael R. Hayden. Variations on a gene: rare and common variants in abca1 and their impact on hdl cholesterol levels and atherosclerosis. Annual Review of Nutrition, 26(1):105–129, August 2006. URL: http://dx.doi.org/10.1146/annurev.nutr.26.061505.111214, doi:10.1146/annurev.nutr.26.061505.111214. This article has 121 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.nutr.26.061505.111214)

[14. (Zarubica2006ABCA1) Ana Zarubica, Doriane Trompier, and Giovanna Chimini. Abca1, from pathology to membrane function. Pflügers Archiv - European Journal of Physiology, 453(5):569–579, July 2006. URL: http://dx.doi.org/10.1007/s00424-006-0108-z, doi:10.1007/s00424-006-0108-z. This article has 53 citations.](https://doi.org/10.1007/s00424-006-0108-z)

[15. (Wang2022Role) Jing Wang, Qianqian Xiao, Luyun Wang, Yan Wang, Daowen Wang, and Hu Ding. Role of abca1 in cardiovascular disease. Journal of Personalized Medicine, 12(6):1010, June 2022. URL: http://dx.doi.org/10.3390/jpm12061010, doi:10.3390/jpm12061010. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jpm12061010)